TAKEDA PHARMA
-
Torrent Pharma signs non-exclusive patent licensing pact with Takeda Pharma for Vonoprazan
A 2019 study published by the Indian Journal of Gastroenterology revealed that the prevalence of GERD in the Indian population is around 8.2%, with a higher prevalence of around 11.1% in the urban population.
-
Japan's Takeda Pharma to restructure after annual profit slump
-
Takeda launches launches hemophilia drug Adynovate in India
-
Practices and Approaches for Treating Hemoglobinopathies
-
Alembic Pharma gets USFDA nod for diabetes drug
-
Alembic Pharma gets USFDA nod for diabetes drug
-
Alembic Pharma gets tentative nod from USFDA for Febuxostat
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
